ACVR2A
MOLECULAR TARGETactivin A receptor type 2A
ACVR2A (activin A receptor type 2A) is targeted by 6 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).
Compounds Targeting ACVR2A
Ranked by bioassay confidence score (PubChem active assay count × evidence quality).
| # | Compound | Confidence | Active Assays |
|---|---|---|---|
| 1 | alvocidib | 4.52 | 91 |
| 2 | tae 684 | 3.43 | 30 |
| 3 | jnj 7706621 | 3.09 | 21 |
| 4 | lestaurtinib | 3.04 | 20 |
| 5 | kw 2449 | 2.64 | 13 |
| 6 | Dasatinib | 0.69 | 1 |
About ACVR2A as a Drug Target
ACVR2A (activin A receptor type 2A) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 6 compounds with documented ACVR2A interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.
ACVR2A inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.